EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer

Adriana Ferre-Giraldo iD, Manel Castells, Alicia Madurga iD, Ariadna Arbiol-Roca, Maurizio de Rocco-Ponce, Lluís Bassas, Francesc Vigués iD, Sara Larriba iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Adriana Ferre-Giraldo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immune-Inflammatory Processes and Gene Therapeutics Group, Genes, Disease and Therapy Program, Bellvitge Biomedical Research Institute (IDIBELL), 089…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Semen, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Generalitat de Catalunya, Ministerio de Trabajo y Economía Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The need for prostate cancer (PCa)-specific biomarkers that enable more accurate detection of the disease and better prediction of tumor aggressiveness remains ongoing due to the low cancer specificity of PSA screening. Several potential mRNA markers for diagnosing PCa, in tissue and urine, have been reported in the literature. In this study, we aim to explore the potential of selected prostate-specific molecules and transcripts contained in small extracellular vesicles (sEVs) in semen to predict PCa risk reclassification for patients with moderately elevated PSA levels—a clinical scenario where identifying truly non-invasive biomarkers is especially critical. RT-qPCR analysis in semen sEVs successfully showed differential expression of KLK3 and PCA3 genes between PCa and healthy controls, whereas CREB3L4, CCNQ and DUSP23 levels were related to the severity or degree of PCa affectation. Our findings also present strong evidence that classifiers based on combined long transcript levels in semen sEVs serve as effective biomarkers. They can be used alone or in combination with blood PSA and/or semen citric acid levels to improve the diagnosis of PCa and assess its severity and disease progression with high accuracy. This strategy would allow a more comprehensive assessment, increase prognostic accuracy, and facilitate accurate clinical decision-making in the management of PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsSemenExtracellular VesiclesBiomarkers, TumorHumansMaleProstate-Specific AntigenMiddle AgedAgedGene Expression Regulation, NeoplasticAntigens, NeoplasmRNA, MessengerPrognosisKallikreins

Stichwörter der Autor:innen

biomarkermRNAnon-invasive diagnosis/prognosisprostate cancersemen extracellular vesicles

Substanzen

Biomarkers, TumorProstate-Specific AntigenAntigens, Neoplasmprostate cancer antigen 3, humanRNA, MessengerKallikreinsKLK3 protein, human

Autor:innen und Institutionen

  • Immune-Inflammatory Processes and Gene Therapeutics Group, Genes, Disease and Therapy Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • Urology Service, Bellvitge University Hospital-ICS, 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • Territorial Clinical Laboratory Metropolitan South, Bellvitge University Hospital, 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • Andrology Service-Puigvert Foundation, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), 08025 Barcelona, Barcelona, Spain.

ORCID-Profile: Adriana Ferre-Giraldo, Alicia Madurga, Francesc Vigués, Sara Larriba

Förderung

  • Instituto de Salud Carlos III
  • Generalitat de Catalunya
  • Ministerio de Trabajo y Economía Social
  • Researchers Consolidation Program

Zitieren

APA

Ferre-Giraldo, A., Castells, M., Madurga, A., Arbiol-Roca, A., de Rocco-Ponce, M., Bassas, L., Vigués, F., & Larriba, S. (2025). Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199562

Vancouver

Ferre-Giraldo A, Castells M, Madurga A, Arbiol-Roca A, de Rocco-Ponce M, Bassas L, et al. Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199562

BibTeX
@article{FerreGiraldo2025,
  author = {Ferre-Giraldo, Adriana and Castells, Manel and Madurga, Alicia and Arbiol-Roca, Ariadna and de Rocco-Ponce, Maurizio and Bassas, Lluís and Vigués, Francesc and Larriba, Sara},
  title = {Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199562}
}
Kostenlos starten →